Vimentin Antikörper (Biotin)
-
- Target Alle Vimentin (VIM) Antikörper anzeigen
- Vimentin (VIM)
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser Vimentin Antikörper ist konjugiert mit Biotin
-
Applikation
- Immunohistochemistry (IHC)
- Verwendungszweck
- Mouse Anti-Human Vimentin, Biotinylated
- Kreuzreaktivität (Details)
- Vimentin antibody will recognize most mammalian Vimentin except mouse and rat.
- Produktmerkmale
- Collagen & Extracellular Matrix Proteins
- Immunogen
- Purified Human Vimentin.
- Isotyp
- IgG1
- Top Product
- Discover our top product VIM Primärantikörper
-
anti-Vimentin (VIM) (AA 371-466) antibody
VIM Reaktivität: Human, Maus, Ratte, Schwein, Rind (Kuh), Affe WB, ELISA, FACS, IHC (p), ICC, IHC (fro), IF (p), IF (cc) Wirt: Kaninchen Polyclonal unconjugated
anti-Vimentin (VIM) antibodyKO Validated VIM Reaktivität: Human WB, IHC, ELISA, IF, IHC (p), ICC, IP, IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Vimentin (VIM) antibodyVIM Reaktivität: Säugetier WB, FACS, IHC (p), ICC Wirt: Maus Monoclonal VI-01 unconjugated
anti-Vimentin (VIM) antibodyVIM Reaktivität: Human, Maus, Ratte, Schwein, Huhn WB, IHC (p), ICC, IP Wirt: Maus Monoclonal VI-10 unconjugated
anti-Vimentin (VIM) antibodyVIM Reaktivität: Human, Maus WB, IF, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB41034 unconjugated
anti-Vimentin (VIM) (AA 1-200) antibodyVIM Reaktivität: Human WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Vimentin (VIM) antibodyVIM Reaktivität: Human WB, IHC, ICC, IP Wirt: Maus Monoclonal C8 unconjugated
anti-Vimentin (VIM) (AA 430-457), (C-Term) antibodyVIM Reaktivität: Human WB, IF, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB16691 unconjugated
anti-Vimentin (VIM) (AA 41-140) antibodyVIM Reaktivität: Human WB, ELISA, IF, IP Wirt: Maus Monoclonal 3E9 unconjugated
anti-Vimentin (VIM) (AA 2-466) antibodyVIM Reaktivität: Human WB, IHC, ELISA, FACS Wirt: Maus Monoclonal 3A1F2 unconjugated
-
- Applikationshinweise
- Immunohistochemistry.< div class='ty-product-feature'>< div class='ty-product-feature__label'>Cross Reactivity< div class='ty-product-feature__value'>Vimentin antibody will recognize most mammalian Vimentin except mouse and rat.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Reconstitute with H20. Mix gently, wash the sides of the vial and wait 30-60 seconds before use.
- Konzentration
- 1 mg/ml in PBS (after reconstitution).
- Lagerung
- -20 °C
- Informationen zur Lagerung
- -20°C
-
- Target
- Vimentin (VIM)
- Andere Bezeichnung
- Vimentin (VIM Produkte)
- Hintergrund
-
Target Description: Vimentin expression in human malignant glioma cells depends on cellular density, algorithms of drug delivery and chemo/radio treatment. Vimentin and detyrosinated microtubules provide structural support for the extensive microtentacles observed in detached tumor cells and a mechanism to promote successful metastatic spread. Primary colorectal carcinomas display aberrant expression of vimentin, and have activated Notch and TGFbeta signaling pathways. Vimentin is a strong arterial substrate for transglutaminases. Transglutaminase-mediated vimentin dimerization results in a novel unifying pathway by which vasodilatory and remodeling responses may be regulated. Ablation of vimentin expression inhibits migration and invasion of colon and breast cancer cell lines.< div class='ty-product-feature'>< div class='ty-product-feature__label'>Cross Reactivity< div class='ty-product-feature__value'>Vimentin antibody will recognize most mammalian Vimentin except mouse and rat.
- Pathways
- Caspase Kaskade in der Apoptose
-
